It was all about the green at this week's Cannabis World Congress in New York. That's the green of money, not marijuana leaves. Exhibitors showing off hemp oils, vaping devices, edibles and a lot more were on display, but the most popular attendee could have been Rob Hunt, a partner at Tuatara Capital. He's the guy who writes the checks to fund development of cannabis products. Tuatara Capital is a private equity company launched last year to make cannabis-related investments. 'Last year alone there was $5.8 billion in legal cannabis sales in the United States,' explained Hunt. 'That number is expected to top $10 billion in two years. You're talking about a $75 billion dollar plus industry by 2020.' Tuatara Capital focuses on four main investment areas: cultivation, processing, research and testing, and consumer retail. '
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.